Catalogue Search | MBRL
Are you sure you want to remove the book from the shelf?
{{itemTitle}}
86
result(s) for
"Women chief executive officers - United States"
Sort by:
Becoming a dangerous woman : embracing risk to change the world
\"Pat Mitchell is a serial ceiling smasher. A former news reporter and news anchor, she was the first woman to host a nationally syndicated daily talk show, the first woman president of Turner Broadcasting, the first woman president of PBS and of CNN Productions. She has been on Variety's list of \"Most Powerful Women in Hollywood\" and Forbes' list of \"Women Changing the World.\" Today, she is the curator of the groundbreaking global TEDWomen conference. Pat Mitchell is seventy-four years old, and she is a dangerous woman. What makes Mitchell dangerous is her lifelong insistence on redefining power on her terms, and in leveraging that power to manifest her vision of a better world. In Becoming a Dangerous Woman, she shares her intimate stories of taking a hammer to all that glass, and offers mentoring to women who want to manifest their own personal or public uprisings. A media matriarch and visionary leader, Mitchell is ready to bestow all that she knows, and the lessons she's learned the hard way, to make it easier for the generations following her. Not only does she share her experiences--the private struggles and the public battles--she offers readers personal stories from other world-changing women who have faced dangerous times by becoming dangerous women. From Abigail Disney, who is shaking up Hollywood to fund women-headed movies, to Rada Boric, who is poised to become the next president of Croatia, Mitchell invites readers to join the dangerous, disruptive women around the world--women who are creating a more just and liberated life for everyone\"-- Provided by publisher.
Book
The Last Male Bastion
Not until 1997 did a female become chief executive officer of a Fortune 500 corporation (Jill Barad, at Mattel Toy Co. Women’s progress since that time has been in fits and starts, exceedingly slow. The number of women CEOs reached 4 in 1999 only to slide back to 2 in 2001. Meanwhile, while not reaching anything approaching parity, women made significant strides in politics (as senators, cabinet secretaries and governors), in not-for-profit spheres (as CEOs of health care and hospital organizations or of United Way chapters, with budgets of billions of dollars), and at colleges and universities (23 % have female presidents or chancellors). Currently, 3%, or 15, of Fortune 500 CEOs are women.
After examining in detail the educations, career progressions, pronouncements and observations, as well as family lives, of the 19 women who have risen to the top (sitting and former CEOs), this book asks, and attempts to answer, two questions:
Why haven’t more women reached the CEO suite?How might women in business better position themselves to ascend to the pinnacle?
Douglas M. Branson received his B.A. from the University of Notre Dame and his J.D. from Northwestern University. He earned an LL.M. from the University of Virginia, specializing in corporate law and securities regulation. Before joining the faculty at Pittsburgh, Professor Branson taught at Seattle University. He has been a visiting professor at a number of schools, including the University of Alabama as Charles Tweedy Distinguished Visiting Professor, the University of Hong Kong as Paul Hastings Distinguished Visiting Professor, the University of Washington (Seattle) as Condon-Faulknor Distinguished Professor, Cornell University, Arizona State University, Washington University (St. Louis), and universities in Australia, New Zealand, Hong Kong, Malaysia, Indonesia, Belgium, Ireland, France, Germany, Spain, South Africa, and England. He holds a permanent faculty appointment as Senior Fellow at the University of Melbourne, Australia, in its Masters of Law Program.
eBook
The last male bastion
Presents a systematic approach to the subject why, proportionaly, so few women occupy seats of power in public companies. This book examines a well-defined group (not random); defined by the single most important criteria, success; with success defined in one and only one way, as promotion to CEO of a Fortune 500 corporation
Publication
Who Takes the Floor and Why: Gender, Power, and Volubility in Organizations
Although past research has noted the importance of both power and gender for understanding volubility—the total amount of time spent talking—in organizations, to date, identifying the unique contributions of power and gender to volubility has been somewhat elusive. Using both naturalistic data sets and experiments, the present studies indicate that while power has a strong, positive effect on volubility for men, no such effect exists for women. Study 1 uses archival data to examine the relationship between the relative power of United States senators and their talking behavior on the Senate floor. Results indicate a strong positive relationship between power and volubility for male senators, but a non-significant relationship for female senators. Study 2 replicates this effect in an experimental setting by priming the concept of power and shows that though men primed with power talk more, women show no effect of power on volubility. Mediation analyses indicate that this difference is explained by women's concern that being highly voluble will result in negative consequences (i.e., backlash). Study 3 shows that powerful women are in fact correct in assuming that they will incur backlash as a result of talking more than others—an effect that is observed among both male and female perceivers. Implications for the literatures on volubility, power, and previous studies of backlash are discussed.
Journal Article
The new CEOs
The New CEOs looks at the women and people of color leading Fortune 500 companies, exploring the factors that have helped them achieve success and their impact on the business world and society more broadly. As recently as fifteen years ago, there had only been three women CEOs of Fortune 500 companies, and no African Americans. As of July 2010, there had been 73 women, African American, Latino, and Asian CEOs of Fortune 500 companies—some well-known, like Carly Fiorina of Hewlett Packard, and some less-known. Richard L. Zweigenhaft and G. William Domhoff look at these 'new CEOs' closely. Weaving compelling interview excerpts with new research, the book traces how these new CEOs came to power, questions whether they differ from white male Fortune 500 CEOs in meaningful ways, asks whether the companies that hired them differ from other companies, and discusses what we can learn about power in America from the emergence of these new CEOs. As Americans continue to debate corporate compensation, glass ceilings, and 'colorblind' relationships, The New CEOs shares information critical to understanding our current situation and looks toward the future in our increasingly globalized world.
eBook
Corporate governance and financial characteristic effects on the extent of corporate social responsibility disclosure
Purpose - This study aims to investigate the relationship between corporate governance and financial characteristics and the extent of corporate social responsibility (CSR) disclosure in the USA. These corporate governance and financial characteristics are the board meetings, average age of board members, presence of women on the board, the board's size, chief executive officer duality, financial leverage, profitability, company's size, board composition and board's commitment to CSR. Design/methodology/approach - The sample consists of 100 companies from the Fortune 500 list for 2011. The environmental, social and governance disclosure score calculated by Bloomberg is used as a proxy for the extent of CSR disclosure. A multiple linear regression was incorporated to investigate the association of corporate characteristics with CSR disclosure. Findings - Results indicate that the company's size, the board commitment to CSR and profitability were found to be positively associated with the extent of CSR disclosure, while financial leverage is related negatively with the extent of CSR disclosure. Research limitations/implications - The research is based only on the presence or absence of CSR items in CSR disclosure, and it ignores the quality dimension which can lead to misinterpretation. The results should not be generalized as the sample was based on US companies for 2011. Originality/value - The study assists stakeholders to identify US companies through the extent of CSR disclosures which contributes to the understanding of determinants of CSR disclosure to improve the implementation of disclosure guidelines.
Journal Article
Women CEO Deans of US Schools and Colleges of Pharmacy
Objective. Seventy-four women served as chief executive officer (CEO) deans of US schools and colleges of pharmacy from January 1988-December 2020. This study examined the characteristics of those women with the objective of providing information useful for preparing future women deans.
Methods. Public domain resources were accessed to obtain information about women pharmacy CEO deans, including names of institution(s) where individuals had served or were serving, dates of service, academic background, whether they were a founding dean, and whether they had served or were serving in other academic higher education positions. Descriptive statistics (means, medians, standard deviations, and percentages) were used for data comparisons (quantitative research). Finally, three early women CEO deans provided perspectives about their deanships (qualitative research).
Results. The median length of service was six years for women in office as of December 31, 2020, and eight years for women who had completed deanships. The percentage of deans holding a Doctor of Philosophy (PhD) declined to 32.4%, while there was a concurrent rise in deans having a Doctor of Pharmacy (PharmD) degree (58.8%); 79.4% of deans in office and 77% of all women deans had a professional pharmacy degree (BSPharm, PharmD, or both). Women had served or were currently serving as CEO deans at a wide variety of pharmacy schools. The percentage of schools with women deans has declined in recent years to 24%.
Conclusion. Recommendations are put forward to prepare future women deans including increased mentoring and creation of an advanced leadership program aimed at potential deans.
Journal Article
An Update on the Progress Toward Gender Equity in US Academic Pharmacy
Objective. To evaluate the status of gender equity in US pharmacy education since the two previous publications on the topic in 2004 and 2014.
Methods. Data were gathered from existing national databases, internal American Association of Colleges of Pharmacy (AACP) databases, AACP meeting minutes, published reports, scholarly articles, pharmacy association websites, individual school websites, and LinkedIn profiles. Differences between men and women were evaluated on degree completion, discipline, rank, tenure status, research, leadership development, leadership positions, salaries, and professional awards. Comparisons were also made to academic medicine and dentistry.
Results. Fifty-one percent of full-time faculty members across all academic pharmacy disciplines are women. The percentage of women at the rank of professor was 36.6%, compared to 25% in 2014. Of the 2992 tenured or tenure track pharmacy faculty, 39.2% were women. Out of 388 department chairs, 146 were women. Throughout 2014-2021, there were 121 chief executive officer (CEO) dean permanent appointments, with men holding 91 (75.2%) and women holding 30 (24.8%). Women received 29.7% of the National Institutes of Health grants awarded to pharmacy schools compared to men (70.3%), although women’s funding amount was higher. In both the pharmacy practice discipline and all sciences disciplines, the total salary across all ranks and years in rank was significantly higher for men than women, even for department chairs, but there were no differences for CEO deans. To date, women have received 13% of four national pharmacy organizations’ top 13 awards.
Conclusion. Since 2014, some achievement gaps have narrowed, but areas of concern still exist and need continued attention and resources so inequities can be eliminated. Women in academic pharmacy need mentoring and support to extend throughout the trajectory of their careers in areas such as academic advancement, grant applications, salary negotiation, leadership pursuit, and award applications.
Journal Article
The Ultimate Glass Ceiling Revisited: The Presence of Women on Corporate Boards
Has the diversity of corporate boards of directors improved? Should it? What role does diversity play in reducing corporate wrongdoing? Will diversity result in a more focused board of directors or more board autonomy? Examining the state of Tennessee as a case study, the authors collected data on the board composition of publicly traded corporations and compared those data to an original study conducted in 1995. Data indicate only a modest improvement in board diversity. This article discusses reasons for the scarcity of women on boards and concludes that, to enhance strategic decisions, board membership should reflect the corporation's consumer population. Thus, women are a critical but overlooked resource. Areas for future research are also considered.
Journal Article
Association of women leaders in the C-suite with hospital performance
BackgroundWomen comprise 50% of the healthcare workforce, but only about 25% of senior leadership positions in the USA. No studies to our knowledge have investigated the performance of hospitals led by women versus those led by men to evaluate the potential explanation that the inequity reflects appropriate selection due to skill or performance differences.MethodsWe conducted a descriptive analysis of the gender composition of hospital senior leadership (C-suite) teams and cross-sectional, regression-based analyses of the relationship between gender composition, hospital characteristics (eg, location, size, ownership), and financial, clinical, safety, patient experience and innovation performance metrics using 2018 data for US adult medical/surgical hospitals with >200 beds. C-suite positions examined included chief executive officer (CEO), chief financial officer (CFO) and chief operating officer (COO). Gender was obtained from hospital web pages and LinkedIn. Hospital characteristics and performance were obtained from American Hospital Directory, American Hospital Association Annual Hospital Survey, Healthcare Cost Report Information System and Hospital Consumer Assessment of Healthcare Providers and Systems surveys.ResultsOf the 526 hospitals studied, 22% had a woman CEO, 26% a woman CFO and 36% a woman COO. While 55% had at least one woman in the C-suite, only 15.6% had more than one. Of the 1362 individuals who held one of the three C-suite positions, 378 were women (27%). Hospital performance on 27 of 28 measures (p>0.05) was similar between women and men-led hospitals. Hospitals with a woman CEO performed significantly better than men-led hospitals on one financial metric, days in accounts receivable (p=0.04).ConclusionHospitals with women in the C-suite have comparable performance to those without, yet inequity in the gender distribution of leaders remains. Barriers to women’s advancement should be recognised and efforts made to rectify this inequity, rather than underusing an equally skilled pool of potential women leaders.
Journal Article